- Home
- WSR vs DNTH Comparison
WSR vs DNTH Comparison
Compare WSR & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSR
- DNTH
- Stock Information
- Founded
- WSR 1998
- DNTH 2015
- Country
- WSR United States
- DNTH United States
- Employees
- WSR N/A
- DNTH N/A
- Industry
- WSR Real Estate Investment Trusts
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- WSR Real Estate
- DNTH Health Care
- Exchange
- WSR Nasdaq
- DNTH Nasdaq
- Market Cap
- WSR 628.6M
- DNTH 606.2M
- IPO Year
- WSR 2010
- DNTH N/A
- Fundamental
- Price
- WSR $12.60
- DNTH $21.50
- Analyst Decision
- WSR Strong Buy
- DNTH Strong Buy
- Analyst Count
- WSR 2
- DNTH 8
- Target Price
- WSR $15.00
- DNTH $53.00
- AVG Volume (30 Days)
- WSR 252.6K
- DNTH 389.6K
- Earning Date
- WSR 07-30-2025
- DNTH 08-07-2025
- Dividend Yield
- WSR 4.29%
- DNTH N/A
- EPS Growth
- WSR 26.93
- DNTH N/A
- EPS
- WSR 0.61
- DNTH N/A
- Revenue
- WSR $155,128,000.00
- DNTH $6,524,000.00
- Revenue This Year
- WSR $2.00
- DNTH N/A
- Revenue Next Year
- WSR $5.14
- DNTH N/A
- P/E Ratio
- WSR $20.69
- DNTH N/A
- Revenue Growth
- WSR 6.69
- DNTH 102.36
- 52 Week Low
- WSR $11.78
- DNTH $13.37
- 52 Week High
- WSR $15.36
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- WSR 52.21
- DNTH 61.73
- Support Level
- WSR $12.40
- DNTH $19.90
- Resistance Level
- WSR $12.64
- DNTH $22.49
- Average True Range (ATR)
- WSR 0.21
- DNTH 1.43
- MACD
- WSR -0.00
- DNTH 0.22
- Stochastic Oscillator
- WSR 51.04
- DNTH 64.11
About WSR Whitestone REIT
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.